Table Of Content. The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners Outputs...

Transcription

1 Table Of Content The European Influenza Surveillance Scheme... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Institut Pasteur... 6 Health Division... 6 Nphs Communicable Disease Surveillance Centre Wales... 6 Niedersächsisches Landesgesundheitsamt - National Influenza Centre... 6 National Institute Of Public Health And The Environment... 6 Robert Koch Institut... 6 Scottish Center For Infection And Environmental Health Scotland... 6 Institut De Salud Carlos Iii... 6 Universita Di Genova... 6 Hospices Civils De Lyon... 6 Istituto Superiore Di Sanita... 6 Laboratoire National De Sante... 6 National Disease Surveillance Centre... 6 University College Dublin National Virus Reference Laboratory... 6 Health Protection Agency Northern Ireland... 6 National Institute Of Hygiene... 6 Universita Degli Studi Di Milano - Instituto Di Virologia... 6 National Public Health Authority Of Slovakia... 6 Instituto Nacional De Saude... 6 Institute Of Public Health... 6 West Of Scotland Specialist Virology Centre Scotland... 6 National Institute Of Public Health... 6 State Public Health Agency - Laboratory Of Virology... 6 Royal College Of General Practioners... 6 Institute Of Public Health... 6 National Institute Of Public Health And The Environment... 6 Irish College Of General Practitioners... 6 Erasmus Uniersity Rotterdam... 6 Norwegian Institute Of Public Health... 6 Open Rome - Groupes Regionaux D'observation De La Grippe... 6 Swedish Institute For Infectious Disease Control... 6 Bundesministerium Gesundheit Und Frauen... 6 Statens Serum Institut... 6 Cantacuzino Institute... 6 Outputs Original Full Information (Dec 2008) Page 1/13

2 The European Influenza Surveillance Scheme JA GPSD [705038] START DATE: 01/09/2003 END DATE: 01/09/2006 DURATION: 36 month(s) CURRENT STATUS: Finalised PROGRAMME TITLE: First Programme of Community action in the field of public health ( ) PROGRAMME PRIORITY: - CALL: Health Threats (Ht 2003) TOPIC: Enhancing the capability of responding rapidly and in a co-ordinated fashion to health threats EC CONTRIBUTION: EUR KEYWORDS: PORTFOLIO: Communicable diseases Page 2/13

3 SUMMARY General objectives The general aim is to contribute to a reduction in the burden of disease associated with influenza in the area covered by EISS, by collecting and exchanging timely information on influenza activity, providing relevant information about influenza to health professionals and the general public, contributing to the annual determination of the influenza vaccine content and contributing to European influenza pandemic preparedness activities. EISS was aiming at covering all EU Member States by , the end of this contract period. Strategic relevance and contribution to the public health programme The European Influenza Surveillance Scheme (EISS) is a dedicated and diseasespecific European surveillance network co-financed to contribute, with regard to influenza information for the purposes of, the Community Network on epidemiological surveillance and control of communicable diseases established by Decision 2119/98/EC. The main tasks are to report to the Community Network epidemiological data on influenza activity in the Community and to contribute to improving surveillance and laboratory preparedness for an influenza pandemic. Methods and means The participating institutions (primary care sentinel surveillance networks, virological laboratories, national influenza centres, and national infectious disease surveillance centres) report clinical cases of influenza-like illness and/or acute respiratory infection and virological test results to a central EISS database over the Internet ( Data is entered each week and all members have access to the database. The database is the basis for the Weekly Electronic Bulletin. The case definitions laid down by Commission Decision 2003/353/EC are used for reporting epidemiological data on influenza activity to the Community network on communicable diseases. Annual meetings are organised to allow e.g. an exchange of information, the presentation of new initiatives and the integration of new members. In addition, two Task Groups meetings per annum are held to deal with issues of importance to the EISS project. The findings/decisions of the Task Group are submitted to the EISS group, discussed at the plenary meeting and are then published. EISS was also intended to extend its activities to all of the EU Member States, with an initial priority to include Finland, Austria and Greece. Further development of the website and electronic data transfers from the EISS members to the EISS database and from the EISS database to the EC Portal` and WHO (FluNet) were set up. Page 3/13

4 Laboratory quality control study was performed in 2004 by the Laboratoire de Virologie at the Université Claude Bernard in Lyon and a clinical surveillance quality control study was also performed. A Community Network of Reference Laboratories (CNRL) for Human Influenza was established. A detailed inventory of laboratory methods in the individual laboratories of the CNRL is carried out to assess the level of pandemic planning preparedness. A laboratory testing procedure manual was written. Laboratories in the CNRL were encouraged to use the procedures described in the manual to enhance the quality of surveillance. Standardized reagents database. Implementation of an ordering system on the EISS website that will provide CNRLs with readily available reagents used for routine surveillance and specialised analysis of emerging virus variants or potentially pandemic viruses. Molecular database. Implementation of this database will enhance the possibilities to detect influenza virus strains drifting away from the vaccine strain and will allow the surveillance of antiviral resistance. A Who is who` and resources list was set up to make an inventory of laboratory capacities and facilities to give rapid access to qualified persons for specific needs as a contribution to influenza pandemic preparedness in Europe. Pandemic outbreak protocol. This protocol will describe on the laboratory and epidemiological level what is needed to be prepared for an influenza pandemic. The laboratory protocol is tested by a simulation exercise. Contacts with animal influenza surveillance schemes are made in order to exchange information important for humans in relation to a pandemic threat, and for harmonisation and standardisation of laboratory procedures. New surveillance activities: EISS will initiate a number of new surveillance activities. These include a mapping project and the collection of data on vaccination uptake. Reports are published for each of these projects. The EISS group presented at least one publication at the end of each influenza season (e.g. in Eurosurveillance). Provide co-ordinated support, training, and knowledge-transfer to new national networks joining EISS, in particular in the New Member States. Expected outcomes period The progress of EISS can be evaluated on the basis of a number of specific outputs and deliverables provided during the influenza seasons 2003/2004, 2004/2005 and 2005/2006: - Reports to the Community Network, once a procedure is established; - Coverage of all Member States by The publication of the Weekly Electronic Bulletin on the EISS website ( during each influenza season on a weekly basis. This bulletin summarises influenza activity (clinical and virological) in the area covered by EISS. - At the end of each influenza season, publication of a manuscript describing the influenza activity in Europe. - The publication of an Annual Report. - Project reports. - Protocols and reports on the operation of the Community Network of Reference Laboratories for Human Influenza in Europe; - Establishment of a comprehensive database which includes clinical, virological and, Page 4/13

5 antiviral resistance and molecular data that allows a better and more advanced analysis (e.g. modelling) of the impact of influenza an d the burden of disease; this database will be fully accessible to the members of the Community Network and to the European Centre for Disease Prevention and Control (ECDC). - The laboratory testing procedures manual. - The new databases (standardised reagents database and molecular data database) will be added to the existing databases that EISS manages. - The EISS List of Resources and Outbreak Protocol will be available to EISS members and to the members of the Community Network and the ECDC, but may not be made available to the general public; - A discussion forum will be added to the EISS website - EISS presents more information/data on other respiratory viruses of importance on the EISS website e.g. RSV and, possibly also, SARS coronavirus activity only where necessary in order to facilitate and support differential diagnosis for influenza; EISS has a policy of making public data/information via its website, where appropriate,. Except for the list of resources and the outbreak protocol, all of the deliverables listed above will be published on the EISS website. Page 5/13

6 COORDINATOR, LEADER CONTACT AND PARTNERS COORDINATOR NIVEL (Netherlands Institute For Health Services Research) (NIVEL (Netherlands Institute For Health Services Research)) Drieharingstraat BJ Utrecht Netherlands Project leader contact Name: Paget John j.paget@nivel.nl Phone: PARTNERS Institut Pasteur Country: France Health Division Country: Malta Nphs Communicable Disease Surveillance Centre Wales Country: United Kingdom Page 6/13

7 Niedersächsisches Landesgesundheitsamt - National Influenza Centre Country: Germany National Institute Of Public Health And The Environment Country: United Kingdom Robert Koch Institut Country: Germany Scottish Center For Infection And Environmental Health Scotland Country: United Kingdom Institut De Salud Carlos Iii Country: Spain Universita Di Genova Country: Italy Page 7/13

8 Hospices Civils De Lyon Country: France Istituto Superiore Di Sanita Country: Italy Laboratoire National De Sante Country: Luxembourg National Disease Surveillance Centre Country: Ireland University College Dublin National Virus Reference Laboratory Country: Ireland Health Protection Agency Northern Ireland Country: United Kingdom National Institute Of Hygiene Page 8/13

9 Country: Poland Universita Degli Studi Di Milano - Instituto Di Virologia Country: Italy National Public Health Authority Of Slovakia Country: Slovakia Instituto Nacional De Saude Country: Portugal Institute Of Public Health Country: Belgium West Of Scotland Specialist Virology Centre Scotland Country: United Kingdom National Institute Of Public Health Page 9/13

10 Country: Czech Republic State Public Health Agency - Laboratory Of Virology Country: Latvia Royal College Of General Practioners Country: United Kingdom Institute Of Public Health Country: Slovenia National Institute Of Public Health And The Environment Country: Netherlands Irish College Of General Practitioners Country: Ireland Erasmus Uniersity Rotterdam Page 10/13

11 Country: Netherlands Norwegian Institute Of Public Health Country: Norway Open Rome - Groupes Regionaux D'observation De La Grippe Country: France Swedish Institute For Infectious Disease Control Country: Sweden Bundesministerium Gesundheit Und Frauen Country: Austria Statens Serum Institut Country: Denmark Cantacuzino Institute Page 11/13

12 Country: Romania Page 12/13

13 Powered by TCPDF ( OUTPUTS Original Full Information (Dec 2008) NIVEL (Netherlands Institute For Health Services Research) The European Influenza Surveillance Scheme (EISS) Published on: 01/09/ Page 13/13